Leucid Bio
Fahima Kausar is a highly experienced professional in the field of immunology and virology, currently serving as Team Lead and Senior Scientist at LEUCID BIO since July 2017, where responsibilities include the design, construction, and testing of CAR T cells. Prior to this role, Fahima worked as a Research Associate at University College London from November 2015 to June 2017, focusing on the impact of dual viral infections in COPD, PCD, and asthma. Fahima Kausar holds a Ph.D. in Viral Immunology, along with a Master's Degree in Immunology and a Bachelor's Degree in Biology, all earned from Imperial College London between 2007 and 2015.
This person is not in any teams
Leucid Bio
1 followers
Leucid Bio is a pioneering biotech company developing cell therapies for refractory cancers, especially solid tumors. Leucid was founded to translate 20 years of King's College London (King's) research in the CAR-T field and is led by a highly experienced management team with both scientific and commercial expertise. As part ofLeucid's ongoing relationship with King's, it benefits from exclusive access to and resources from the deep scientific, clinical, and manufacturing expertise of Dr. Maher and his academic team of immuno-oncology experts.